Home / Business / Business News / Article / Novartis India to acquire Pfizer trademarks 'Minipress' and 'Minipres' for Rs 1,250 crore

Novartis India to acquire Pfizer trademarks 'Minipress' and 'Minipres' for Rs 1,250 crore

The transaction involves the acquisition of the trademarks registered in India and certain related intellectual property rights for a total aggregate consideration of Rs 1,250 crore

  • WhatsAppBookmarkBookmark
Listen to this article :
Representational Image. File pic.

Representational Image. File pic.

Novartis India Ltd on Monday announced that its Board of Directors has approved the acquisition of the trademarks 'Minipress' and 'Minipres' from Pfizer Inc. USA and Pfizer Products Inc. USA for a total consideration of approximately Rs 1,250 crore.

In a regulatory filing, the company said the transaction involves the acquisition of the trademarks registered in India and certain related intellectual property rights for a total aggregate consideration of Rs 1,250 crore.

Read Next Story
Gold futures decline to Rs 1.52 lakh per 10gm; silver futures at Rs 2.36 lakh per kg›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All